Ikena Oncology

Jilted by Bristol Myers, Ikena cuts headcount by 35% in retreat from drug discovery
Fierce Biotech
Fri, 01/19/24 - 09:28 am
Ikena Oncology
Bristol Myers Squibb
layoffs
AACR 2023 – Hippo makes a splash
EP Vantage
Wed, 04/19/23 - 10:07 am
Vivace Therapeutics
VT3989
AACR
Novartis
Sanofi
Ikena Oncology
Three Biopharma Companies Making Their Nasdaq Debut
BioSpace
Mon, 03/29/21 - 10:49 am
IPOs
NASDAQ
Design Therapeutics
Edgewise Therapeutics
Ikena Oncology
Biotech IPO market looks to ramp back up as BMS partner Ikena and its immunometabolism therapies eye public offering
Endpoints
Mon, 03/8/21 - 09:15 pm
IPOs
Ikena Oncology
Kyn Therapeutics
NASDAQ
Ikena bags $120M to advance growing pipeline of cancer drugs
Fierce Biotech
Tue, 01/5/21 - 10:23 am
Ikena Oncology
cancer
oncology
funding